Genoa Ventures Elevates Landon Merrill to Partner, Strengthening Leadership in Science-Driven Investing [Yahoo! Finance]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
SAN FRANCISCO, October 22, 2024 BUSINESS WIRE )--Genoa Ventures, a venture capital firm investing in science-driven companies of consequence, is proud to announce the promotion of Landon Merrill from Principal to Partner. Merrill joined Genoa in June 2021, following a two-decade career spanning the life sciences industry, with leadership roles in companies ranging across sectors, including R&D tools, medical devices, automation, and pharma services. Merrill brings a diverse and deep skill set honed through his technical and commercial leadership across organizations from startups to multinationals. His expertise in structured, rigorous product strategy and development, combined with a keen understanding of team dynamics and relationship building, make him an invaluable asset in deal diligence and portfolio company support. "My passion for biology comes from a natural curiosity about the world and a commitment to stewardship of it," said Merrill. "At Genoa, I have the privilege of
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- Spatial Genomics and Transcriptomics Research Analysis Report 2024-2030: Emergence of High-Throughput Sequencing Platforms Fuels Market Growth [Yahoo! Finance]Yahoo! Finance
- Sphere Fluidics Strengthens Global Commercial Teams and Establishes Direct Sales and Support Channel in North America [Yahoo! Finance]Yahoo! Finance
- 10x Genomics to Present at the Wolfe Research 2024 Healthcare ConferencePR Newswire
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Barclays PLC from $21.00 to $19.00. They now have an "overweight" rating on the stock.MarketBeat
- Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance]Yahoo! Finance
TXG
Earnings
- 10/29/24 - Beat
TXG
Sec Filings
- 11/18/24 - Form 4
- 11/8/24 - Form SC
- 11/5/24 - Form SC
- TXG's page on the SEC website